help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 60, No. 5 841-847
doi:10.1210/jcem-60-5-841
Copyright © 1985 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BUCALA, R.
Right arrow Articles by CERAMI, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BUCALA, R.
Right arrow Articles by CERAMI, A.

Increased Levels of 16{alpha}-Hydroxyestrone-Modified Proteins in Pregnancy and in Systemic Lupus Erythematosus*

RICHARD BUCALA, ROBERT G. LAHITA, JACK FISHMAN and ANTHONY CERAMI

Laboratories of Medical Biochemistry, Immunology, and Biochemical Endocrinology, The Rockefeller University New York, New York 10021

Address all correspondence and requests for reprints to: Richard Bucala, Laboratory of Medical Biochemistry, Rockefeller University, Box 277, 1230 York Avenue, New York, New York 10021

The ketolic estrogen 16{alpha}-hydroxyestrone (16{alpha}OHE) reacts with lysine residues, forming stable covalent adducts with proteins. To determine the extent of protein modification by 16{alpha}OHE in vivo, we measured the level of 16{alpha}OHElysine present within proteins of varying half-lives obtained from normal subjects, patients with systemic lupus erythematosus (SLE), and pregnant women. The latter groups have higher than normal levels of plasma 16{alpha}OHE. The proteins analyzed were membrane proteins of the red cell and the lymphocyte and basement membrane proteins of the glomerulus. We report that elevated levels of plasma 16{alpha}OHE led to increased formation of 16{alpha}OHE-protein adducts and that the level of these adducts increases with the half-life of the protein. In the case of erythrocyte membrane proteins, pregnant women and women with SLE had significantly higher mean levels of 16{alpha}OHE-lysine than normal women (normal, 5.2 pmol 16{alpha}OHE-lysine/mmol leucine; SLE, 15.7; pregnant, 24.9). A similar elevation in the modification of lymphocyte proteins in women was found (normal, 15.6; SLE, 40.5). Since the degree of protein modification also was dependent on the ambient level of free 16{alpha}OUE, these measurements provide a useful indicator of the long term 16aOHE status of an individual. The modification of proteins by 16{alpha}OHE may be a link in the relationship between female hormones, pregnancy, and systemic lupus erythematosus.

* This work was supported by the Kroc Foundation and Grant CA-22795.

Received August 30, 1984.




This article has been cited by other articles:


Home page
LupusHome page
I Mendez, J Alcocer-Varela, A Parra, A Lava-Zavala, D A de la Cruz, D Alarcon-Segovia, and F Larrea
Neuroendocrine dopaminergic regulation of prolactin release in systemic lupus erythematosus: a possible role of lymphocyte-derived prolactin
Lupus, January 1, 2004; 13(1): 45 - 53.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1985 by The Endocrine Society